Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aptinyx Inc. - Common Stock (NQ: APTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aptinyx Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Arcturus Therapeutics (NASDAQ:ARCT) shares rose 25.93% to $60.75 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5... 
Via Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures COVID-19
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Aptinyx Inc. (APTX) Q2 2021 Earnings Call Transcript
APTX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
CORRECTING and REPLACING Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
From Aptinyx Inc.
Via Business Wire
Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
From Aptinyx Inc.
Via Business Wire
28 Stocks Moving in Tuesday's Pre-Market Session
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also... 
Via Benzinga
Aptinyx to Participate in 2021 Wedbush PacGrow Healthcare Virtual Conference
From Aptinyx Inc.
Via Business Wire
Aptinyx to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in William Blair Biotech Focus Conference 2021
From Aptinyx Inc.
Via Business Wire
Aptinyx Stock Looks Promising If You’re Willing to Be Patient
When you're shopping for ground-floor biotech opportunities, it pays to be patient and diligent. APTX stock is looking good here. 
Via InvestorPlace
Aptinyx to Participate in Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
From Aptinyx Inc.
Via Business Wire
Aptinyx to Participate in Upcoming Investor Conferences
From Aptinyx Inc.
Via Business Wire
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19 Product Safety
Aptinyx Provides Updates On Mid-Stage NYX-783 Program In PTSD Patients
After a Type C meeting with the FDA, Aptinyx Inc (NASDAQ: APTX) has finalized the design of its Phase 2b program for NYX-783 in patients with post-traumatic... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers NeuroMetrix (NASDAQ:NURO) stock r... 
Via Benzinga
Aptinyx Provides Update on NYX-783 Development Program for the Treatment of Post-Traumatic Stress Disorder
From Aptinyx Inc.
Via Business Wire
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
46 Stocks Moving In Friday's Mid-Day Session
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,... 
Via Benzinga
Mid-Day Market Update: Markets Mixed; Novan Shares Spike Higher
Midway through trading Friday, the Dow traded down 0.07% to 34,442.46 while the NASDAQ rose 0.09% to 14,033.42. The S&P also rose, gaining 0.01% to 4,239.73. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
66 Biggest Movers From Yesterday
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares... 
Via Benzinga
75 Biggest Movers From Yesterday
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock. NextDecade... 
Via Benzinga
Aptinyx Inc. (APTX) Q1 2021 Earnings Call Transcript
APTX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares jumped 72.4% to $20.55 amid increased retail investor interest in the stock. NextDecade Corporation (NASDAQ: NEXT... 
Via Benzinga
Aptinyx Reports First Quarter 2021 Financial Results and Highlights
From Aptinyx Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.